Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.

Medina, C; Carretero, G; Ferrandiz, C; Dauden, E; Vanaclocha, F; Gómez-García, F J; Herrera-Ceballos, E; De la Cueva-Dobao, P; Belinchón, I; Sánchez-Carazo, J L; Alsina, M; López-Estebaranz, J L; Ferrán, M; Carrascosa, J M; Torrado, R; Argila, D; Rivera, R; Jiménez-Puya, R; García-Doval, I

Medina, C; Carretero, G; Ferrandiz, C; Dauden, E; Vanaclocha, F; Gómez-García, F J; Herrera-Ceballos, E; De la Cueva-Dobao, P; Belinchón, I; Sánchez-Carazo, J L; Alsina, M; López-Estebaranz, J L; Ferrán, M; Carrascosa, J M; Torrado, R; Argila, D; Rivera, R; Jiménez-Puya, R; García-Doval, I.

Affiliation

Medina C; Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.

J Eur Acad Dermatol Venereol ; 29(5): 858-64, 2015 May.

Article in En | MEDLINE | ID: mdl-25185962

Subject(s)

Biological Products/adverse effects; Dermatologic Agents/adverse effects; Psoriasis/drug therapy; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Antibodies, Monoclonal/adverse effects; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents/adverse effects; Infant; Male; Middle Aged; Registries; Spain; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Psoriasis / Biological Products / Dermatologic Agents Type of study: Observational_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google